NYSE:QGENLife Sciences
Qiagen Automation Push And Sustainability Aims Meet Undervalued Stock Story
Qiagen (NYSE:QGEN) has launched new automation platforms for DNA and RNA extraction in clinical laboratories.
The line up includes sustainability focused consumables, QIAsprint Connect, QIAsymphony Connect, and QIAmini.
The products target a wide range of clinical and research settings that rely on scalable sample preparation workflows.
Qiagen, trading at $51.08, is putting fresh attention on lab automation and sustainability with this new product wave. The company’s shares have returned...